Lubiprostone
NDC 0254-3029, Lubiprostone, capsule, gelatin coated, from Par Health USA, LLC.
- Product NDC
- 0254-3029
- Status
- Listed
- Labeler
- Par Health USA, LLC
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA021908
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0254-3029 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LUBIPROSTONE24 ug/1
Pharmacologic classes
Chloride Channel Activator [EPC]; Chloride Channel Activators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0254-3029-02 | 00254302902 | 60 CAPSULE, GELATIN COATED in 1 BOTTLE (0254-3029-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9d958b58-6c4f-4bb1-8660-cf5eac256440NADAC price for package 00254302902
GET /v1/drugs/nadac/00254302902
Use it
Look up 0254-3029 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0254-3029 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0254-3029. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.